Breaking News on Global Pharmaceutical Technology & Manufacturing

Headlines > July 2017

« Previous month Next month »

Merck & Co API operations hit by cyberattack yet to restart production

31-Jul-2017 - API operations hit by the Petya cyberattack have not been restored according to Merck & Co Inc, which expects difficulties fulfilling some product orders and lower 2017 profits partly due...

German lyophilisation ramp-up could be delayed into next year, Recipharm

31-Jul-2017 - A lyophilisation expansion announced in 2013 at an aseptic facility in Wasserburg, Germany has been delayed due to lengthy approval processes, says Recipharm.

Takeda licenses Zejula in deal that will see Tesaro supply it with API

31-Jul-2017 - Takeda has agreed to pay $100m (€85m) upfront for rights to make and sell to Tesaro Inc’s drug Zejula in Japan, South Korea, Taiwan, Russia and Australia.

Alexion ends Moderna mRNA pact

28-Jul-2017 - Alexion Pharmaceuticals says it is reducing R&D operations and terminating mRNA-focused preclinical partnerships.

Avantor site launches with biopharma lean

27-Jul-2017 - Avantor has opened a research centre in New Jersey, US offering gene to protein expression and drug delivery contract services.

Dirty work for drug makers: wastewater can be used for antibiotics development, says researcher

27-Jul-2017 - A researcher at South Africa’s Stellenbosch University (SU) says biosurfactants made by bugs in municipal wastewater could help drug makers develop new antibiotics.

Reig Jofre says it has resolved penicillin raw materials supply issue

27-Jul-2017 - Raw material supply problems that impacted its penicillin business last year have been resolved according to Reig Jofre.

GSK dropping 22% of its pharma portfolio

GSK trimming manufacturing network in pharma product and R&D shake-up

27-Jul-2017 - GSK will simplify its in-house manufacturing and cut CMO use by 25% under plans to strengthen its pharmaceutical business.

Lilly says manufacturing and pricing swayed revenue rise

27-Jul-2017 - Manufacturing efficiencies and positive pricing boosted Eli Lilly’s margins in the second quarter, offsetting lower sales outside the US.

Lonza sets CHF7.5bn 2022 sales target citing pharma drivers

26-Jul-2017 - Lonza Group AG has predicted it will generate annual revenue of CHF7.5bn ($7.9bn) by 2022, citing recent acquisition Capsugel and its new Visp-based Ibex manufacturing service as drivers.

News in brief

Unichem outlines manufacturing plan for generic Hyzaar

26-Jul-2017 - Unichem Laboratories Limited has confirmed it will make its generic version of Hyzaar for the US market at three plants in India.

New drugs now: UK provides funds for smaller drug makers

26-Jul-2017 - The UK government has announced £6m ($7.8m) funding for small and medium sized enterprises (SMEs) to speed up access to new medicines.

Recipharm installs dedicated production line for prostate cancer depot

26-Jul-2017 - Recipharm has installed a dedicated production line to make prostate cancer drug Liproca Depot for Swedish pharma firm LIDDS AB.

Torbay Pharma opens plant with sterile injectables capacity in UK

25-Jul-2017 - Torbay Pharmaceuticals has opened a £26m injectable drug manufacturing facility in Paignton, UK.

STA to supply intermediate for Tesaro 's $117k-a-year cancer drug Zejula

25-Jul-2017 - Tesaro Inc has hired STA Pharmaceutical Co. Ltd to supply intermediates for its recently approved, $117k-a-year, ovarian cancer drug Zejula (niraparib).

News in brief

Mitsubishi Tanabe to pay $1.1bn for Parkinson's drug formulator Neuroderm

25-Jul-2017 - Mitsubishi Tanabe Pharma has agreed to pay $1.1bn (€943m) to acquire Parkinson’s disease focused formulation and drug-device developer Neuroderm Ltd.

ChargePoint expands to target Central and North America

25-Jul-2017 - ChargePoint Technology has announced expansion plans to increase its offering across the US, Canada, Mexico and Puerto Rico.

Chongquing Succeway made APIs in undeclared plant and faked records says ANSM

24-Jul-2017 - French regulators says Chongquing Succeway Pharmaceutical Co Ltd should recall APIs made at its plant in Chongquing after inspectors found evidence of record manipulation and an undeclared manufacturing area.

Site shut, 875 jobs cut: Endo to close US manufacturing facility

24-Jul-2017 - Endo International has announced it will close its manufacturing plant in Huntsville, Alabama and eliminate 875 positions.

TPI Enterprises buys Vistin opiates assets and confirms Portugal plant plan

21-Jul-2017 - TPI Enterprises has bought Vistin Pharma ASA’s opiates and tabletting division for A$25.4m ($201.m) in a deal designed to expand the firm beyond its narcotic raw materials business.

update - comment from Unite

GSK says UK manufacturing cuts not Brexit related

20-Jul-2017 - GSK has announced a shakeup of its UK network, shelving plans for Ulverston biopharma plant, mooting the sale of its cephalosporin antibiotics business and pledging to invest in HIV and...

WHO prequalifies Mylan's India unit to supply TB drug API

20-Jul-2017 - The WHO has prequalified Indian-based Mylan Laboratories Ltd to supply the tuberculosis drug ingredient protionamide.

The serialisation stragglers: industry concern for complacency

20-Jul-2017 - The US Food and Drug Administration’s (FDA) decision to delay serialisation regulations shows drug companies and contract manufacturers are still unprepared, say industry representatives.

Update - comments from EMA and EFPIA

EU to probe if drug firms' pre-submission meetings sway EMA approval decisions

19-Jul-2017 - Drug firms’ pre-submission meetings with the EMA may influence agency approval decisions according to European Ombudsman Emily O' Reilly who has launched an investigation 

Glenmark selects Cyndea to make gel capsule drugs

19-Jul-2017 - Cyndea Pharma and Glenmark Pharmaceuticals have partnered to make generic soft-gelatin capsule products for multiple markets.

« Previous month Next month »

Key Industry Events


Access all events listing

Our events, Shows & Conferences...